| Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba S Resik, A Tejeda, P Mas Lago, M Diaz, A Carmenates, L Sarmiento, ... The Journal of infectious diseases 201 (9), 1344-1352, 2010 | 170 | 2010 |
| Priming after a fractional dose of inactivated poliovirus vaccine S Resik, A Tejeda, RW Sutter, M Diaz, L Sarmiento, N Alemañi, G Garcia, ... New England Journal of Medicine 368 (5), 416-424, 2013 | 160 | 2013 |
| A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers H Toledo, A Baly, O Castro, S Resik, J Laferté, F Rolo, L Navea, ... Vaccine 19 (30), 4328-4336, 2001 | 151 | 2001 |
| Experiencia cubana en inmunización, 1962–2016 LL Ambrón, LIE Torres, AP Carreras, BMG Santana, MÁG Sardiña, ... Revista Panamericana de Salud Pública 42, e34, 2018 | 72 | 2018 |
| Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba S Resik, A Tejeda, O Mach, M Fonseca, M Diaz, N Alemany, G Garcia, ... Vaccine 33 (2), 307-313, 2015 | 64 | 2015 |
| Coxsackievirus A6 and enterovirus 71 causing hand, foot and mouth disease in Cuba, 2011–2013 MC Fonseca, L Sarmiento, S Resik, Y Martínez, LH Hung, L Morier, ... Archives of virology 159, 2451-2455, 2014 | 55 | 2014 |
| Limitations to contact tracing and phylogenetic analysis in establishing HIV type 1 transmission networks in Cuba S Resik, P Lemey, LH Ping, V Kouri, J Joanes, J Pérez, AM Vandamme, ... AIDS research and human retroviruses 23 (3), 347-356, 2007 | 53 | 2007 |
| Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: association between injection quality and immunogenicity S Resik, A Tejeda, O Mach, C Sein, N Molodecky, C Jarrahian, L Saganic, ... Vaccine 33 (43), 5873-5877, 2015 | 42 | 2015 |
| Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients MCM Villalba, OV Ramírez, MM Jiménez, AA Garcia, JM Alfonso, ... Clinical Immunology 220, 108576, 2020 | 41 | 2020 |
| Prevalence of Chlamydia trachomatis in human immunodeficiency virus-infected women in Cuba V Kouri, J Cartaya, ME Rodríguez, M Muné, Y Soto, S Resik, J Bravo, ... Memórias do Instituto Oswaldo Cruz 97, 1073-1077, 2002 | 38 | 2002 |
| Type 1 diabetes associated and tissue transglutaminase autoantibodies in patients without type 1 diabetes and coeliac disease with confirmed viral infections L Sarmiento, JA Galvan, E Cabrera‐Rode, L Aira, C Correa, S Sariego, ... Journal of medical virology 84 (7), 1049-1053, 2012 | 34 | 2012 |
| Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba V Kourí, SM Eng, ME Rodríguez, S Resik, O Orraca, PS Moore, Y Chang Revista Panamericana de Salud Pública 15, 320-325, 2004 | 32 | 2004 |
| Molecular epidemiology of Kaposi's sarcoma herpesvirus (KSHV) in Cuban and German patients with Kaposi's sarcoma (KS) and asymptomatic sexual contacts V Kouri, A Marini, R Doroudi, S Nambiar, ME Rodriguez, V Capo, S Resik, ... Virology 337 (2), 297-303, 2005 | 25 | 2005 |
| Infecciones por citomegalovirus AG Díaz Martínez, MC Valdés Abreu, S Resik Aguirre Revista Cubana de Medicina General Integral 14 (3), 270-278, 1998 | 23 | 1998 |
| Boosting immune responses following fractional-dose inactivated poliovirus vaccine: a randomized, controlled trial S Resik, A Tejeda, M Diaz, H Okayasu, C Sein, NA Molodecky, ... The Journal of infectious diseases 215 (2), 175-182, 2017 | 22 | 2017 |
| Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: a phase I Trial in healthy adults in Cuba S Resik, A Tejeda, M Fonseca, N Alemañi, M Diaz, Y Martinez, G Garcia, ... Vaccine 32 (42), 5399-5404, 2014 | 22 | 2014 |
| Association of early nasopharyngeal immune markers with COVID-19 clinical outcome: predictive value of CCL2/MCP-1 B Sierra, AB Pérez, E Aguirre, C Bracho, O Valdés, N Jimenez, ... Open forum infectious diseases 7 (10), ofaa407, 2020 | 19 | 2020 |
| Immunogenicity of intramuscular fractional dose of inactivated poliovirus vaccine S Resik, O Mach, A Tejeda, V Jeyaseelan, M Fonseca, M Diaz, ... The Journal of Infectious Diseases 221 (6), 895-901, 2020 | 19 | 2020 |
| Isolation of Coxsackievirus A24 variant from patients with hemorrhagic conjunctivitis in Cuba, 2008–2009 MC Fonseca, L Sarmiento, S Resik, N Pereda, H Rodríguez, V Kourí, ... Journal of clinical virology 53 (1), 77-81, 2012 | 18 | 2012 |
| Molecular epidemiology and KSHV K1 subtypes in a Cuban AIDS-Kaposi's sarcoma population V Kouri, X Liang, ME Rodriguez, V Capo, S Resik, J Barrios, B Mantecon, ... Aids 19 (9), 984-987, 2005 | 17 | 2005 |
Luis SarmientoSenior Research Scientist, Lund UniversityVerified email at med.lu.se
